Global Commercial Infant Formulas Market Research Report 2025

Commercial Infant Formulas Market

The global market for Commercial Infant Formulas was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China"s birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children"s consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children"s Industry shows that in 80% of families in China, children"s expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Commercial Infant Formulas, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercial Infant Formulas.

The Commercial Infant Formulas market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Commercial Infant Formulas market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Commercial Infant Formulas manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Commercial Infant Formulas Market Report

Core Chapters

1.1 Product Definition

1.2 Commercial Infant Formulas by Type

1.2.1 Global Commercial Infant Formulas Market Value Comparison by Type (2024 VS 2031)

1.2.2 Cow Milk Protein-based Formulas

1.2.3 Soy-based Formulas

1.2.4 Protein Hydrolysate Formulas

1.2.5 Others

1.3 Commercial Infant Formulas by Application

1.3.1 Global Commercial Infant Formulas Market Value by Application (2024 VS 2031)

1.3.2 0-6 Month Infant

1.3.3 6-12 Month Infant

1.3.4 12-24 Month Infant

1.3.5 Others

1.4 Global Commercial Infant Formulas Market Size Estimates and Forecasts

1.4.1 Global Commercial Infant Formulas Revenue 2020-2031

1.4.2 Global Commercial Infant Formulas Sales 2020-2031

1.4.3 Global Commercial Infant Formulas Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2.1 Global Commercial Infant Formulas Sales Market Share by Manufacturers (2020-2025)

2.2 Global Commercial Infant Formulas Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Commercial Infant Formulas Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Commercial Infant Formulas, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Commercial Infant Formulas, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Commercial Infant Formulas, Product Type & Application

2.7 Global Key Manufacturers of Commercial Infant Formulas, Date of Enter into This Industry

2.8 Global Commercial Infant Formulas Market Competitive Situation and Trends

2.8.1 Global Commercial Infant Formulas Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Commercial Infant Formulas Players Market Share by Revenue

2.8.3 Global Commercial Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Commercial Infant Formulas Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Commercial Infant Formulas Sales by Region: 2020-2031

3.2.1 Global Commercial Infant Formulas Sales by Region: 2020-2025

3.2.2 Global Commercial Infant Formulas Sales by Region: 2026-2031

3.3 Global Commercial Infant Formulas Revenue by Region: 2020-2031

3.3.1 Global Commercial Infant Formulas Revenue by Region: 2020-2025

3.3.2 Global Commercial Infant Formulas Revenue by Region: 2026-2031

3.4 North America Commercial Infant Formulas Market Facts & Figures by Country

3.4.1 North America Commercial Infant Formulas Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Commercial Infant Formulas Sales by Country (2020-2031)

3.4.3 North America Commercial Infant Formulas Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Commercial Infant Formulas Market Facts & Figures by Country

3.5.1 Europe Commercial Infant Formulas Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Commercial Infant Formulas Sales by Country (2020-2031)

3.5.3 Europe Commercial Infant Formulas Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Commercial Infant Formulas Market Facts & Figures by Region

3.6.1 Asia Pacific Commercial Infant Formulas Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Commercial Infant Formulas Sales by Region (2020-2031)

3.6.3 Asia Pacific Commercial Infant Formulas Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Commercial Infant Formulas Market Facts & Figures by Country

3.7.1 Latin America Commercial Infant Formulas Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Commercial Infant Formulas Sales by Country (2020-2031)

3.7.3 Latin America Commercial Infant Formulas Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Commercial Infant Formulas Market Facts & Figures by Country

3.8.1 Middle East and Africa Commercial Infant Formulas Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Commercial Infant Formulas Sales by Country (2020-2031)

3.8.3 Middle East and Africa Commercial Infant Formulas Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Commercial Infant Formulas Sales by Type (2020-2031)

4.1.1 Global Commercial Infant Formulas Sales by Type (2020-2025)

4.1.2 Global Commercial Infant Formulas Sales by Type (2026-2031)

4.1.3 Global Commercial Infant Formulas Sales Market Share by Type (2020-2031)

4.2 Global Commercial Infant Formulas Revenue by Type (2020-2031)

4.2.1 Global Commercial Infant Formulas Revenue by Type (2020-2025)

4.2.2 Global Commercial Infant Formulas Revenue by Type (2026-2031)

4.2.3 Global Commercial Infant Formulas Revenue Market Share by Type (2020-2031)

4.3 Global Commercial Infant Formulas Price by Type (2020-2031)

5.1 Global Commercial Infant Formulas Sales by Application (2020-2031)

5.1.1 Global Commercial Infant Formulas Sales by Application (2020-2025)

5.1.2 Global Commercial Infant Formulas Sales by Application (2026-2031)

5.1.3 Global Commercial Infant Formulas Sales Market Share by Application (2020-2031)

5.2 Global Commercial Infant Formulas Revenue by Application (2020-2031)

5.2.1 Global Commercial Infant Formulas Revenue by Application (2020-2025)

5.2.2 Global Commercial Infant Formulas Revenue by Application (2026-2031)

5.2.3 Global Commercial Infant Formulas Revenue Market Share by Application (2020-2031)

5.3 Global Commercial Infant Formulas Price by Application (2020-2031)

6.1 Nestle

6.1.1 Nestle Company Information

6.1.2 Nestle Description and Business Overview

6.1.3 Nestle Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Nestle Commercial Infant Formulas Product Portfolio

6.1.5 Nestle Recent Developments/Updates

6.2 Mead Johnson＆Company，LLC

6.2.1 Mead Johnson＆Company，LLC Company Information

6.2.2 Mead Johnson＆Company，LLC Description and Business Overview

6.2.3 Mead Johnson＆Company，LLC Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mead Johnson＆Company，LLC Commercial Infant Formulas Product Portfolio

6.2.5 Mead Johnson＆Company，LLC Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Commercial Infant Formulas Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 Feihe

6.4.1 Feihe Company Information

6.4.2 Feihe Description and Business Overview

6.4.3 Feihe Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Feihe Commercial Infant Formulas Product Portfolio

6.4.5 Feihe Recent Developments/Updates

6.5 Yili

6.5.1 Yili Company Information

6.5.2 Yili Description and Business Overview

6.5.3 Yili Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Yili Commercial Infant Formulas Product Portfolio

6.5.5 Yili Recent Developments/Updates

6.6 Mengniu

6.6.1 Mengniu Company Information

6.6.2 Mengniu Description and Business Overview

6.6.3 Mengniu Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Mengniu Commercial Infant Formulas Product Portfolio

6.6.5 Mengniu Recent Developments/Updates

6.7 Biostime

6.7.1 Biostime Company Information

6.7.2 Biostime Description and Business Overview

6.7.3 Biostime Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Biostime Commercial Infant Formulas Product Portfolio

6.7.5 Biostime Recent Developments/Updates

6.8 Beingmate

6.8.1 Beingmate Company Information

6.8.2 Beingmate Description and Business Overview

6.8.3 Beingmate Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beingmate Commercial Infant Formulas Product Portfolio

6.8.5 Beingmate Recent Developments/Updates

6.9 Synutra International Inc

6.9.1 Synutra International Inc Company Information

6.9.2 Synutra International Inc Description and Business Overview

6.9.3 Synutra International Inc Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Synutra International Inc Commercial Infant Formulas Product Portfolio

6.9.5 Synutra International Inc Recent Developments/Updates

6.10 Wondersun

6.10.1 Wondersun Company Information

6.10.2 Wondersun Description and Business Overview

6.10.3 Wondersun Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Wondersun Commercial Infant Formulas Product Portfolio

6.10.5 Wondersun Recent Developments/Updates

6.11 Wissun

6.11.1 Wissun Company Information

6.11.2 Wissun Description and Business Overview

6.11.3 Wissun Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Wissun Commercial Infant Formulas Product Portfolio

6.11.5 Wissun Recent Developments/Updates

6.12 Shijiazhuang Junlebao Dairy Co., Ltd.

6.12.1 Shijiazhuang Junlebao Dairy Co., Ltd. Company Information

6.12.2 Shijiazhuang Junlebao Dairy Co., Ltd. Description and Business Overview

6.12.3 Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Product Portfolio

6.12.5 Shijiazhuang Junlebao Dairy Co., Ltd. Recent Developments/Updates

6.13 Brightdairy Dairy Co., Ltd

6.13.1 Brightdairy Dairy Co., Ltd Company Information

6.13.2 Brightdairy Dairy Co., Ltd Description and Business Overview

6.13.3 Brightdairy Dairy Co., Ltd Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Brightdairy Dairy Co., Ltd Commercial Infant Formulas Product Portfolio

6.13.5 Brightdairy Dairy Co., Ltd Recent Developments/Updates

6.14 Sanyuan Group

6.14.1 Sanyuan Group Company Information

6.14.2 Sanyuan Group Description and Business Overview

6.14.3 Sanyuan Group Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Sanyuan Group Commercial Infant Formulas Product Portfolio

6.14.5 Sanyuan Group Recent Developments/Updates

6.15 Yinqiao Group

6.15.1 Yinqiao Group Company Information

6.15.2 Yinqiao Group Description and Business Overview

6.15.3 Yinqiao Group Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Yinqiao Group Commercial Infant Formulas Product Portfolio

6.15.5 Yinqiao Group Recent Developments/Updates

6.16 Longdan Dairy

6.16.1 Longdan Dairy Company Information

6.16.2 Longdan Dairy Description and Business Overview

6.16.3 Longdan Dairy Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Longdan Dairy Commercial Infant Formulas Product Portfolio

6.16.5 Longdan Dairy Recent Developments/Updates

7.1 Commercial Infant Formulas Industry Chain Analysis

7.2 Commercial Infant Formulas Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Commercial Infant Formulas Production Mode & Process Analysis

7.4 Commercial Infant Formulas Sales and Marketing

7.4.1 Commercial Infant Formulas Sales Channels

7.4.2 Commercial Infant Formulas Distributors

7.5 Commercial Infant Formulas Customer Analysis

8.1 Commercial Infant Formulas Industry Trends

8.2 Commercial Infant Formulas Market Drivers

8.3 Commercial Infant Formulas Market Challenges

8.4 Commercial Infant Formulas Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Commercial Infant Formulas Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

 Table 2. Global Commercial Infant Formulas Market Value by Application (2024 VS 2031) & (US$ Million)

 Table 3. Global Commercial Infant Formulas Market Competitive Situation by Manufacturers in 2024

 Table 4. Global Commercial Infant Formulas Sales (Kiloton) of Key Manufacturers (2020-2025)

 Table 5. Global Commercial Infant Formulas Sales Market Share by Manufacturers (2020-2025)

 Table 6. Global Commercial Infant Formulas Revenue (US$ Million) by Manufacturers (2020-2025)

 Table 7. Global Commercial Infant Formulas Revenue Share by Manufacturers (2020-2025)

 Table 8. Global Market Commercial Infant Formulas Average Price (US$/Ton) of Key Manufacturers (2020-2025)

 Table 9. Global Key Players of Commercial Infant Formulas, Industry Ranking, 2022 VS 2023 VS 2024

 Table 10. Global Key Manufacturers of Commercial Infant Formulas, Manufacturing Sites & Headquarters

 Table 11. Global Key Manufacturers of Commercial Infant Formulas, Product Type & Application

 Table 12. Global Key Manufacturers of Commercial Infant Formulas, Date of Enter into This Industry

 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 14. Global Commercial Infant Formulas by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Infant Formulas as of 2024)

 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 16. Global Commercial Infant Formulas Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 17. Global Commercial Infant Formulas Sales by Region (2020-2025) & (Kiloton)

 Table 18. Global Commercial Infant Formulas Sales Market Share by Region (2020-2025)

 Table 19. Global Commercial Infant Formulas Sales by Region (2026-2031) & (Kiloton)

 Table 20. Global Commercial Infant Formulas Sales Market Share by Region (2026-2031)

 Table 21. Global Commercial Infant Formulas Revenue by Region (2020-2025) & (US$ Million)

 Table 22. Global Commercial Infant Formulas Revenue Market Share by Region (2020-2025)

 Table 23. Global Commercial Infant Formulas Revenue by Region (2026-2031) & (US$ Million)

 Table 24. Global Commercial Infant Formulas Revenue Market Share by Region (2026-2031)

 Table 25. North America Commercial Infant Formulas Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 26. North America Commercial Infant Formulas Sales by Country (2020-2025) & (Kiloton)

 Table 27. North America Commercial Infant Formulas Sales by Country (2026-2031) & (Kiloton)

 Table 28. North America Commercial Infant Formulas Revenue by Country (2020-2025) & (US$ Million)

 Table 29. North America Commercial Infant Formulas Revenue by Country (2026-2031) & (US$ Million)

 Table 30. Europe Commercial Infant Formulas Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 31. Europe Commercial Infant Formulas Sales by Country (2020-2025) & (Kiloton)

 Table 32. Europe Commercial Infant Formulas Sales by Country (2026-2031) & (Kiloton)

 Table 33. Europe Commercial Infant Formulas Revenue by Country (2020-2025) & (US$ Million)

 Table 34. Europe Commercial Infant Formulas Revenue by Country (2026-2031) & (US$ Million)

 Table 35. Asia Pacific Commercial Infant Formulas Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

 Table 36. Asia Pacific Commercial Infant Formulas Sales by Region (2020-2025) & (Kiloton)

 Table 37. Asia Pacific Commercial Infant Formulas Sales by Region (2026-2031) & (Kiloton)

 Table 38. Asia Pacific Commercial Infant Formulas Revenue by Region (2020-2025) & (US$ Million)

 Table 39. Asia Pacific Commercial Infant Formulas Revenue by Region (2026-2031) & (US$ Million)

 Table 40. Latin America Commercial Infant Formulas Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 41. Latin America Commercial Infant Formulas Sales by Country (2020-2025) & (Kiloton)

 Table 42. Latin America Commercial Infant Formulas Sales by Country (2026-2031) & (Kiloton)

 Table 43. Latin America Commercial Infant Formulas Revenue by Country (2020-2025) & (US$ Million)

 Table 44. Latin America Commercial Infant Formulas Revenue by Country (2026-2031) & (US$ Million)

 Table 45. Middle East and Africa Commercial Infant Formulas Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 46. Middle East and Africa Commercial Infant Formulas Sales by Country (2020-2025) & (Kiloton)

 Table 47. Middle East and Africa Commercial Infant Formulas Sales by Country (2026-2031) & (Kiloton)

 Table 48. Middle East and Africa Commercial Infant Formulas Revenue by Country (2020-2025) & (US$ Million)

 Table 49. Middle East and Africa Commercial Infant Formulas Revenue by Country (2026-2031) & (US$ Million)

 Table 50. Global Commercial Infant Formulas Sales (Kiloton) by Type (2020-2025)

 Table 51. Global Commercial Infant Formulas Sales (Kiloton) by Type (2026-2031)

 Table 52. Global Commercial Infant Formulas Sales Market Share by Type (2020-2025)

 Table 53. Global Commercial Infant Formulas Sales Market Share by Type (2026-2031)

 Table 54. Global Commercial Infant Formulas Revenue (US$ Million) by Type (2020-2025)

 Table 55. Global Commercial Infant Formulas Revenue (US$ Million) by Type (2026-2031)

 Table 56. Global Commercial Infant Formulas Revenue Market Share by Type (2020-2025)

 Table 57. Global Commercial Infant Formulas Revenue Market Share by Type (2026-2031)

 Table 58. Global Commercial Infant Formulas Price (US$/Ton) by Type (2020-2025)

 Table 59. Global Commercial Infant Formulas Price (US$/Ton) by Type (2026-2031)

 Table 60. Global Commercial Infant Formulas Sales (Kiloton) by Application (2020-2025)

 Table 61. Global Commercial Infant Formulas Sales (Kiloton) by Application (2026-2031)

 Table 62. Global Commercial Infant Formulas Sales Market Share by Application (2020-2025)

 Table 63. Global Commercial Infant Formulas Sales Market Share by Application (2026-2031)

 Table 64. Global Commercial Infant Formulas Revenue (US$ Million) by Application (2020-2025)

 Table 65. Global Commercial Infant Formulas Revenue (US$ Million) by Application (2026-2031)

 Table 66. Global Commercial Infant Formulas Revenue Market Share by Application (2020-2025)

 Table 67. Global Commercial Infant Formulas Revenue Market Share by Application (2026-2031)

 Table 68. Global Commercial Infant Formulas Price (US$/Ton) by Application (2020-2025)

 Table 69. Global Commercial Infant Formulas Price (US$/Ton) by Application (2026-2031)

 Table 70. Nestle Company Information

 Table 71. Nestle Description and Business Overview

 Table 72. Nestle Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 73. Nestle Commercial Infant Formulas Product

 Table 74. Nestle Recent Developments/Updates

 Table 75. Mead Johnson＆Company，LLC Company Information

 Table 76. Mead Johnson＆Company，LLC Description and Business Overview

 Table 77. Mead Johnson＆Company，LLC Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 78. Mead Johnson＆Company，LLC Commercial Infant Formulas Product

 Table 79. Mead Johnson＆Company，LLC Recent Developments/Updates

 Table 80. Abbott Company Information

 Table 81. Abbott Description and Business Overview

 Table 82. Abbott Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 83. Abbott Commercial Infant Formulas Product

 Table 84. Abbott Recent Developments/Updates

 Table 85. Feihe Company Information

 Table 86. Feihe Description and Business Overview

 Table 87. Feihe Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 88. Feihe Commercial Infant Formulas Product

 Table 89. Feihe Recent Developments/Updates

 Table 90. Yili Company Information

 Table 91. Yili Description and Business Overview

 Table 92. Yili Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 93. Yili Commercial Infant Formulas Product

 Table 94. Yili Recent Developments/Updates

 Table 95. Mengniu Company Information

 Table 96. Mengniu Description and Business Overview

 Table 97. Mengniu Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 98. Mengniu Commercial Infant Formulas Product

 Table 99. Mengniu Recent Developments/Updates

 Table 100. Biostime Company Information

 Table 101. Biostime Description and Business Overview

 Table 102. Biostime Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 103. Biostime Commercial Infant Formulas Product

 Table 104. Biostime Recent Developments/Updates

 Table 105. Beingmate Company Information

 Table 106. Beingmate Description and Business Overview

 Table 107. Beingmate Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 108. Beingmate Commercial Infant Formulas Product

 Table 109. Beingmate Recent Developments/Updates

 Table 110. Synutra International Inc Company Information

 Table 111. Synutra International Inc Description and Business Overview

 Table 112. Synutra International Inc Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 113. Synutra International Inc Commercial Infant Formulas Product

 Table 114. Synutra International Inc Recent Developments/Updates

 Table 115. Wondersun Company Information

 Table 116. Wondersun Description and Business Overview

 Table 117. Wondersun Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 118. Wondersun Commercial Infant Formulas Product

 Table 119. Wondersun Recent Developments/Updates

 Table 120. Wissun Company Information

 Table 121. Wissun Description and Business Overview

 Table 122. Wissun Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 123. Wissun Commercial Infant Formulas Product

 Table 124. Wissun Recent Developments/Updates

 Table 125. Shijiazhuang Junlebao Dairy Co., Ltd. Company Information

 Table 126. Shijiazhuang Junlebao Dairy Co., Ltd. Description and Business Overview

 Table 127. Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 128. Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Product

 Table 129. Shijiazhuang Junlebao Dairy Co., Ltd. Recent Developments/Updates

 Table 130. Brightdairy Dairy Co., Ltd Company Information

 Table 131. Brightdairy Dairy Co., Ltd Description and Business Overview

 Table 132. Brightdairy Dairy Co., Ltd Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 133. Brightdairy Dairy Co., Ltd Commercial Infant Formulas Product

 Table 134. Brightdairy Dairy Co., Ltd Recent Developments/Updates

 Table 135. Sanyuan Group Company Information

 Table 136. Sanyuan Group Description and Business Overview

 Table 137. Sanyuan Group Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 138. Sanyuan Group Commercial Infant Formulas Product

 Table 139. Sanyuan Group Recent Developments/Updates

 Table 140. Yinqiao Group Company Information

 Table 141. Yinqiao Group Description and Business Overview

 Table 142. Yinqiao Group Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 143. Yinqiao Group Commercial Infant Formulas Product

 Table 144. Yinqiao Group Recent Developments/Updates

 Table 145. Longdan Dairy Company Information

 Table 146. Longdan Dairy Description and Business Overview

 Table 147. Longdan Dairy Commercial Infant Formulas Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

 Table 148. Longdan Dairy Commercial Infant Formulas Product

 Table 149. Longdan Dairy Recent Developments/Updates

 Table 150. Key Raw Materials Lists

 Table 151. Raw Materials Key Suppliers Lists

 Table 152. Commercial Infant Formulas Distributors List

 Table 153. Commercial Infant Formulas Customers List

 Table 154. Commercial Infant Formulas Market Trends

 Table 155. Commercial Infant Formulas Market Drivers

 Table 156. Commercial Infant Formulas Market Challenges

 Table 157. Commercial Infant Formulas Market Restraints

 Table 158. Research Programs/Design for This Report

 Table 159. Key Data Information from Secondary Sources

 Table 160. Key Data Information from Primary Sources

 Table 161. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Commercial Infant Formulas

 Figure 2. Global Commercial Infant Formulas Market Value Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Commercial Infant Formulas Market Share by Type: 2024 & 2031

 Figure 4. Cow Milk Protein-based Formulas Product Picture

 Figure 5. Soy-based Formulas Product Picture

 Figure 6. Protein Hydrolysate Formulas Product Picture

 Figure 7. Others Product Picture

 Figure 8. Global Commercial Infant Formulas Market Value by Application (2020-2031) & (US$ Million)

 Figure 9. Global Commercial Infant Formulas Market Share by Application: 2024 & 2031

 Figure 10. 0-6 Month Infant

 Figure 11. 6-12 Month Infant

 Figure 12. 12-24 Month Infant

 Figure 13. Others

 Figure 14. Global Commercial Infant Formulas Revenue, (US$ Million), 2020 VS 2024 VS 2031

 Figure 15. Global Commercial Infant Formulas Market Size (2020-2031) & (US$ Million)

 Figure 16. Global Commercial Infant Formulas Sales (2020-2031) & (Kiloton)

 Figure 17. Global Commercial Infant Formulas Average Price (US$/Ton) & (2020-2031)

 Figure 18. Commercial Infant Formulas Report Years Considered

 Figure 19. Commercial Infant Formulas Sales Share by Manufacturers in 2024

 Figure 20. Global Commercial Infant Formulas Revenue Share by Manufacturers in 2024

 Figure 21. Global 5 and 10 Largest Commercial Infant Formulas Players: Market Share by Revenue in Commercial Infant Formulas in 2024

 Figure 22. Commercial Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

 Figure 23. Global Commercial Infant Formulas Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Figure 24. North America Commercial Infant Formulas Sales Market Share by Country (2020-2031)

 Figure 25. North America Commercial Infant Formulas Revenue Market Share by Country (2020-2031)

 Figure 26. U.S. Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 27. Canada Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 28. Europe Commercial Infant Formulas Sales Market Share by Country (2020-2031)

 Figure 29. Europe Commercial Infant Formulas Revenue Market Share by Country (2020-2031)

 Figure 30. Germany Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 31. France Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 32. U.K. Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 33. Italy Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 34. Russia Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 35. Asia Pacific Commercial Infant Formulas Sales Market Share by Region (2020-2031)

 Figure 36. Asia Pacific Commercial Infant Formulas Revenue Market Share by Region (2020-2031)

 Figure 37. China Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 38. Japan Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 39. South Korea Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 40. India Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 41. Australia Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 42. Taiwan Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 43. Indonesia Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 44. Thailand Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 45. Malaysia Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 46. Philippines Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 47. Latin America Commercial Infant Formulas Sales Market Share by Country (2020-2031)

 Figure 48. Latin America Commercial Infant Formulas Revenue Market Share by Country (2020-2031)

 Figure 49. Mexico Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 50. Brazil Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 51. Argentina Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 52. Middle East and Africa Commercial Infant Formulas Sales Market Share by Country (2020-2031)

 Figure 53. Middle East and Africa Commercial Infant Formulas Revenue Market Share by Country (2020-2031)

 Figure 54. Turkey Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 55. Saudi Arabia Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 56. U.A.E Commercial Infant Formulas Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 57. Global Sales Market Share of Commercial Infant Formulas by Type (2020-2031)

 Figure 58. Global Revenue Market Share of Commercial Infant Formulas by Type (2020-2031)

 Figure 59. Global Commercial Infant Formulas Price (US$/Ton) by Type (2020-2031)

 Figure 60. Global Sales Market Share of Commercial Infant Formulas by Application (2020-2031)

 Figure 61. Global Revenue Market Share of Commercial Infant Formulas by Application (2020-2031)

 Figure 62. Global Commercial Infant Formulas Price (US$/Ton) by Application (2020-2031)

 Figure 63. Commercial Infant Formulas Value Chain

 Figure 64. Channels of Distribution (Direct Vs Distribution)

 Figure 65. Bottom-up and Top-down Approaches for This Report

 Figure 66. Data Triangulation

 Figure 67. Key Executives Interviewed